Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

GM Helix Implant,Ti,4.3X16: medical device reports filed with FDA

1,011 reports name it, 2020–2026. Manufacturer given most often on reports: Jjgc. Product code DZE.

1,011
device reports naming the brand
0% of all MAUDE reports · about 160 a year
381
reports, 12 months to August 2026
264 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

1,011 medical device reports received by FDA name the brand "GM Helix Implant,Ti,4.3X16" (endosseous dental implant); the manufacturer given most often on reports is Jjgc; received from March 2020 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

381 reports arrived in the 12 months to August 2026, up 44% from 264 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (72.9%), loss of osseointegration (13%) and difficult to insert (2.1%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

02652Sep 2021: 2Oct 2021: 2Nov 2021: 3Dec 2021: 22022Jan 2022: 9Feb 2022: 3Mar 2022: 7Apr 2022: 4May 2022: 2Jun 2022: 6Jul 2022: 7Aug 2022: 15Sep 2022: 3Oct 2022: 8Nov 2022: 3Dec 2022: 22023Jan 2023: 4Feb 2023: 4Mar 2023: 23Apr 2023: 13May 2023: 26Jun 2023: 12Jul 2023: 7Aug 2023: 9Sep 2023: 5Oct 2023: 7Nov 2023: 19Dec 2023: 152024Jan 2024: 11Feb 2024: 7Mar 2024: 15Apr 2024: 14May 2024: 17Jun 2024: 14Jul 2024: 16Aug 2024: 19Sep 2024: 27Oct 2024: 20Nov 2024: 22Dec 2024: 222025Jan 2025: 19Feb 2025: 19Mar 2025: 15Apr 2025: 7May 2025: 0Jun 2025: 52Jul 2025: 34Aug 2025: 27Sep 2025: 40Oct 2025: 12Nov 2025: 22Dec 2025: 512026Jan 2026: 23Feb 2026: 41Mar 2026: 46Apr 2026: 28May 2026: 36Jun 2026: 21Jul 2026: 25Aug 2026: 36

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01492982020: 1220202021: 2820212022: 6920222023: 14420232024: 20420242025: 29820252026: 2562026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%1,011
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report82%829
Voluntary report0%0
User facility report0%0
Distributor report18%182
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate73772.9%62.8%
Loss of osseointegration13113%22.4%
Difficult to insertthe device was hard to insert212.1%0.4%
Fracturea broken bone60.6%1.6%
Separation failure40.4%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis24524.2%
Painpain, site not specified23823.5%
Inflammationinflammation696.8%
Swelling/ edema636.2%
Hemorrhage/blood loss/bleeding626.1%
Abscessa collection of pus393.9%
Fistula232.3%
Hyperresponsive to stimuli161.6%
Sinus perforation60.6%
Hypersensitivity/allergic reaction50.5%
Numbnessnumbness40.4%
Tissue damage40.4%
Swellingswelling10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureGM Helix Implant,Ti,4.3X16Product code DZEAll MAUDE reports
Reports1,0113,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer82%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about GM Helix Implant,Ti,4.3X16 reports

How many FDA reports name GM Helix Implant,Ti,4.3X16?

1,011 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 381 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (72.9%), loss of osseointegration (13%), difficult to insert (2.1%), fracture (0.6%) and separation failure (0.4%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (82%) and distributor reports (18%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that GM Helix Implant,Ti,4.3X16 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.